Accretion Nutraveda Ltd (544694) — Board Meeting | 27 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
AGM approved director appointments and remuneration revisions
💡 Investor Takeaway
Shareholders endorsed executive pay increases and board composition changes, signaling confidence in leadership continuity.

Accretion Nutraveda held its 5th AGM on 27 August 2026 via video conference, adopting 2026 audited financials and approving director appointments and remuneration revisions for key executives including the Chairman and Managing Director. The meeting concluded at 2:18 PM after a 18-minute session with full director attendance and no auditor qualifications.

📄 View Original Announcement (PDF)

About Accretion Nutraveda Ltd (544694)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹201.42 Cr

View full 544694 stock details →

📡 Get AI alerts when 544694 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 544694 — Free

📊 More 544694 filings

See all 544694 filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day